Search

everythinglearnresearchcommunity

for

Search:↓

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

Cyclosporin and minoxidil promote hair growth.

Neurosteroids help balance brain signals when certain inhibitions are reduced.

SB414 may be an effective treatment for atopic dermatitis by reducing swelling and bacterial infection.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Upadacitinib improved multiple immune-related conditions in one patient.

Compounds 6f and 6g effectively stop prostate cancer cell growth without harming healthy cells.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Cyclosporine effectively treated a woman's stubborn skin condition.

A new cream, DHMEQ, reduces allergic skin inflammation effectively.

Computational techniques can improve drug development for treating certain conditions.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

JAK inhibitors show promise in treating difficult skin diseases.

PM-9 and finasteride effectively inhibit the enzyme that converts testosterone to DHT.

Chemicals called 4-(alkylthio)- and 4-(arylthio)-benzonitrile derivatives can potentially reduce oil production on skin, which could help treat conditions like acne and hair loss.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Spironolactone reduces the number of androgen receptor sites in rat skin by blocking them with its metabolite.

Dyclonine can effectively reduce skin issues by inhibiting the TRPV3 channel.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Oral calcitriol helped improve scleroderma and hair regrowth in a young woman.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

The nanogel with Ciclopirox Olamine is a promising treatment for skin yeast infections.

Cyclosporin A and FK506 can start new hair growth without needing immunosuppression.

JAK inhibitors like tofacitinib are effective and safer for severe alopecia areata than glucocorticosteroids.

L-cystine, D-pantothenat, and miliacin together significantly boost keratinocyte growth and metabolism.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.